GRIFOLS S A/S (NASDAQ:GRFS) Shares Bought by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS grew its holdings in shares of GRIFOLS S A/S (NASDAQ:GRFS) by 3.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 263,500 shares of the biotechnology company’s stock after purchasing an additional 10,000 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in GRIFOLS S A/S were worth $5,560,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GRFS. JPMorgan Chase & Co. increased its position in GRIFOLS S A/S by 856.0% during the 1st quarter. JPMorgan Chase & Co. now owns 1,558,478 shares of the biotechnology company’s stock worth $31,340,000 after purchasing an additional 1,395,461 shares during the period. FIL Ltd boosted its stake in shares of GRIFOLS S A/S by 12.2% during the 1st quarter. FIL Ltd now owns 8,170,942 shares of the biotechnology company’s stock worth $164,318,000 after acquiring an additional 887,474 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of GRIFOLS S A/S by 9.7% during the 1st quarter. First Trust Advisors LP now owns 5,125,719 shares of the biotechnology company’s stock worth $103,078,000 after acquiring an additional 453,032 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of GRIFOLS S A/S by 19.6% during the 1st quarter. Janus Henderson Group PLC now owns 928,736 shares of the biotechnology company’s stock worth $18,674,000 after acquiring an additional 152,417 shares in the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of GRIFOLS S A/S by 628.4% during the 1st quarter. Marshall Wace LLP now owns 133,498 shares of the biotechnology company’s stock worth $2,685,000 after acquiring an additional 115,170 shares in the last quarter. Institutional investors own 19.14% of the company’s stock.

GRFS stock traded down $0.07 on Thursday, reaching $21.77. The company had a trading volume of 118,510 shares, compared to its average volume of 1,233,898. GRIFOLS S A/S has a 1 year low of $17.42 and a 1 year high of $23.03. The company has a current ratio of 2.68, a quick ratio of 0.95 and a debt-to-equity ratio of 1.38. The firm’s fifty day moving average price is $21.83. The company has a market capitalization of $15.02 billion, a P/E ratio of 18.60, a P/E/G ratio of 1.34 and a beta of 1.11.



GRFS has been the topic of several research analyst reports. Zacks Investment Research raised GRIFOLS S A/S from a “sell” rating to a “hold” rating in a research note on Thursday. ValuEngine lowered GRIFOLS S A/S from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. BidaskClub raised GRIFOLS S A/S from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 3rd. Finally, JPMorgan Chase & Co. raised GRIFOLS S A/S from a “neutral” rating to an “overweight” rating and upped their target price for the company from $21.00 to $22.50 in a research note on Thursday, June 27th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. GRIFOLS S A/S currently has a consensus rating of “Hold” and an average price target of $20.75.

About GRIFOLS S A/S

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products.

Read More: What does a hold rating mean?

Want to see what other hedge funds are holding GRFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRIFOLS S A/S (NASDAQ:GRFS).

Institutional Ownership by Quarter for GRIFOLS S A/S (NASDAQ:GRFS)

Receive News & Ratings for GRIFOLS S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRIFOLS S A/S and related companies with MarketBeat.com's FREE daily email newsletter.